Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Phase 3

Terminated

• Conditions: HIV Infections; Peripheral Nervous System Diseases; Pain

• Registration Number: NCT00085761
• Lead Sponsor: NeurogesX

Brief Summary

The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is safe, tolerable and effective in treating painful HIV-associated neuropathy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2004-06-14
• Study First Submitted QC: 2004-06-16
• Study First Posted: 2004-06-17
• Status Verified: 2008-03
• Last Update Submitted: 2008-03-04
• Last Update Posted: 2008-03-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

NeurogesX Investigational Site; 🇺🇸 Annandale, Virginia, United States